Literature DB >> 9217763

Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.

P Garred, J Eugen-Olsen, A K Iversen, T L Benfield, A Svejgaard, B Hofmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9217763     DOI： 10.1016/s0140-6736(05)63874-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.

Authors:  S I Staprans; P J Dailey; A Rosenthal; C Horton; R M Grant; N Lerche; M B Feinberg
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV.

Authors:  A D Sullivan; J Wigginton; D Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

3.  CCR2-64I allele is associated with the progression of AIDS in a Han Chinese population.

Authors:  Lidan Xu; Yuandong Qiao; Xuelong Zhang; Haiming Sun; Jingwei Wang; Donglin Sun; Yan Jin; Yang Yu; Feng Chen; Jing Bai; Hong Ling; Kaili Wang; Songbin Fu
Journal:  Mol Biol Rep       Date:  2009-08-08       Impact factor: 2.316

4.  Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.

Authors:  Rajnish S Dave; Roger J Pomerantz
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Impact of ERCC2 gene polymorphism on HIV-1 disease progression to AIDS among North Indian HIV patients.

Authors:  Ranbir Chander Sobti; Nega Berhane; Salih Abdul Mahdi; Rupinder Kler; Seyed Ali Hosseini; Vijish Kuttiat; Ajay Wanchu
Journal:  Mol Biol Rep       Date:  2010-02-02       Impact factor: 2.316

Review 6.  RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?

Authors:  Sandesh Subramanya; Sang-Soo Kim; N Manjunath; Premlata Shankar
Journal:  Expert Opin Biol Ther       Date:  2010-02       Impact factor: 4.388

Review 7.  Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.

Authors:  J M McNicholl; D K Smith; S H Qari; T Hodge
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

Review 8.  Genetic therapies against HIV.

Authors:  John J Rossi; Carl H June; Donald B Kohn
Journal:  Nat Biotechnol       Date:  2007-12       Impact factor: 54.908

9.  Human immunodeficiency virus type 1 disease progression, CCR5 genotype, and specific immune responses.

Authors:  U Visco-Comandini; C Hultgren; C Broström; M Birk; S Kim; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

10.  Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.

Authors:  Katrien Princen; Sigrid Hatse; Kurt Vermeire; Stefano Aquaro; Erik De Clercq; Lars-Ole Gerlach; Mette Rosenkilde; Thue W Schwartz; Renato Skerlj; Gary Bridger; Dominique Schols
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.